Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic TH2 immune responses and mucosal immunity in mice

Annals of Allergy, Asthma and Immunology

Volumn 99, Issue 5, 2007, Pages 443-452

  Huang, Ching Feng ^a,b   Wang, Chih Chien ^b   Wu, Tzee Chung ^c   Chu, Chia Hsiang ^d   Peng, Ho Jen ^a,c  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CHOLERA TOXIN; CPG OLIGODEOXYNUCLEOTIDE; CYTOKINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; OVALBUMIN;

ADJUVANT THERAPY; ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; IMMUNOTHERAPY; LYMPH NODE CELL; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; SALIVA ANALYSIS; SPLEEN; TH1 CELL; TH2 CELL; VACCINATION;

EID: 36049014372     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60570-4     Document Type: Article

References (31)

1. Mestecky J, Moldoveanu Z, Elson CO. Immune response versus mucosal tolerance to mucosally administered antigens. Vaccine. 2005;23:1800-1803.
2. Strobel S, Mowat AM. Immune responses to dietary antigens: oral tolerance. Immunol Today. 1998;19:173-181.
3. Unger WW, Hauet-Broere F, Jansen W, van Berkel LA, Kraal G, Samsom JN. Early events in peripheral regulatory T cell induction via the nasal mucosa. J Immunol. 2003;171:4592-4603.
4. Cox LS, Linnemann DL, Nolte H, Weldon D, Finegold I, Nelson HS. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol. 2006;117:1021-1035.
5. Di Rienzo V, Marcucci F, Puccinelli P, et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy. 2003;33:206-210.
6. Cosmi L, Santarlasci V, Angeli R, et al. Sublingual immunotherapy with Dermatophagoides monomeric allergoid downregulates allergen-specific immunoglobulin E and increases both interferon-γ- and interleukin-10- production. Clin Exp Allergy. 2006;36:261-272.
7. Arikan C, Bahceciler NN, Deniz G, et al. Bacillus Calmette-Guerin-induced interleukin-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy. Clin Exp Allergy. 2004;34:398-405.
8. Bagnasco M, Altrinetti V, Pesce G, et al. Pharmacokinetics of Der p 2 allergen and derived monomeric allergoid in allergic volunteers. Int Arch Allergy Immunol. 2005;138:197-202.
9. Peng HJ, Chang ZN, Tsai LC, Su SN, Shen HD, Chang CH. Heat denaturation of egg-white proteins abrogates the induction of oral tolerance of specific Th2 immune responses in mice. Scand J Immunol. 1998;48:491-496.
10. Peng HJ, Chang ZN, Han SH, Won MH, Huang BT. Chemical denaturation of ovalbumin abrogates the induction of oral tolerance of specific IgG antibody and DTH responses in mice. Scand J Immunol. 1995;42:297-304.
11. Czerkinsky C, Anjuere F, McGhee JR, et al. Mucosal immunity and tolerance: relevance to vaccine development. Immunol Rev. 1999;70:197-222.
12. Trujillo-Vargas CM, Mayer KD, Bickert T, et al. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses. Clin Exp Allergy. 2005;35:1003-1013.
13. Jiang W, Baker HJ, Smith BF. Mucosal immunization with helicobacter, CpG DNA, and cholera toxin is protective. Infect Immun. 2003;71:40-46.
14. Freytag LC, Clements JD. Mucosal adjuvants. Vaccine. 2005;23:1804-1813.
15. Holmgren J, Harandi AM, Czerkinsky C. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Expert Rev Vaccines. 2003;2:205-217.
16. Peng HJ, Tsai JJ, Chang ZN, Shen HD, Tsai LC, Su SN. Denaturation of ovalbumin abrogates oral induction of airway hyperreactivity and IgG1, IgG2 antibody responses in guinea pigs. Int Arch Allergy Immunol. 1998;117:224-230.
17. Peng HJ, Chang ZN, Kuo SW, Lee CC, Tzau YY. Resting B cells are not antigen-presenting cells in the induction of oral tolerance of specific Th2 immune responses in mice. Int Arch Allergy Immunol. 2000;122:174-181.
18. Roman M, Martin-Orozco E, Goodman JS, et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nature Med. 1997;3:849-854.
19. Jain VV, Kitagaki K, Kline JN. CpG DNA and immunotherapy of allergic airway diseases. Clin Exp Allergy. 2003;33:1330-1335.
20. Adel-Patient K, Bernard H, Ah-Leung S, Creminon C, Wal JM. Peanut- and cow's milk-specific IgE, Th2 cells and local anaphylactic reaction are induced in Balb/c mice orally sensitized with cholera toxin. Allergy. 2005;60:658-664.
21. Eriksson K, Fredriksson M, Nordstrom I, Holmgren J. Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development. Infect Immun. 2003;71:1740-1747.
22. Fromantin C, Jamot B, Cohen J, Piroth L, Pothier P, Kohli E. Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1/Th2-like immune response. J Virol. 2001;75:11010-11016.
23. Means GE, Feeney RE. Chemical Modification of Protein. San Francisco, California: Holden-Day; 1971.
24. Restani P, Ballabio C, Cattaneo A, Isoardi P, Terracciano L, Fiocchi A. Characterization of bovine serum albumin epitopes and their role in allergic reactions. Allergy. 2004;59(suppl 78):21-24.
25. Vila L, Beyer K, Jarvinen KM, Chatchatee P, Bardina L, Sampson HA. Role of conformational and linear epitopes in the achievement of tolerance in cow's milk allergy. Clin Exp Allergy. 2001;31:1599-1606.
26. Westritschnig K, Focke M, Verdino P, et al. Generation of an allergy vaccine by disruption of the three-dimensional structure of the cross-reactive calcium-binding allergen, Phl p 7. J Immunol. 2004;172:5684-5692.
27. Gieni RS, Yang X, Kelso A, Hayglass KT. Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerized ovalbumin: directed induction of T-helper type-1-like activation. Immunology. 1996;87:119-126.
28. Canonica GW, Passalacqua G. Noninjection routes of immunotherapy. J Allergy Clin Immunol. 2003;111:437-448.
29. Fu TJ, Abbott UR, Hatzos C. Digestibility of food allergens and nonallergenic proteins in simulated gastric fluid and simulated intestinal fluid: a comparative study. J Agric Food Chem. 2002;50:7154-7160.
30. + regulatory T cells by oral antigen administration. J Immunol. 2001;167:4245-4253.
31. Barbey C, Donatelli-Dufour N, Batard P, Corradin G, Spertini F. Intranasal treatment with ovalbumin but not the major T cell epitope ovalbumin 323-339 generates interleukin-10 secreting T cells and results in the induction of allergen systemic tolerance. Clin Exp Allergy. 2004;34:654-662.